On March 31, two leading biomedical researchers from Stony Brook University, Lilianne Mujica-Parodi and Gábor Balázsi, joined with colleagues from across the country in Washington, D.C., to meet with congressional offices to discuss the importance of robust federal funding for biomedical research during at The American Institute for Medical and Biological Engineering (AIMBE)’s Capitol Hill Day.
Mujica-Parodi and Balázsi engaged with New York congressional delegation staff to emphasize the critical need for continued and increased federal investment in biomedical science. With the crucial need for the advancement of biomedical technologies and innovations, these researchers underscored how federal support is essential not only for academic and clinical advancements but also for training and retaining top-tier talent in the United States.
“Investing in biomedical research is an investment in the future of healthcare, science, and our nation’s global leadership in innovation,” said Mujica-Parodi, a leading expert of neuroscience. “America’s ability to retain and attract talented scientists depends on the available funding and support, which ultimately drives progress in fields ranging from neurobiology to cancer treatment.”
The Hill meetings highlighted the importance of federal funding not only for maintaining current biomedical research efforts but also for expanding them to meet future challenges. With increasing competition from other countries, including China, the U.S. must prioritize the funding of biomedical research to ensure it remains a global leader in healthcare innovation and scientific advancement.
“The U.S. remains a global leader in innovation, but this leadership is increasingly under threat from competing nations investing heavily in their own biomedical sectors,” said Balázsi, whose expertise focuses on genetic biotechnology. “If we do not increase federal funding, we risk losing our competitive edge and the ability to develop the next generation of groundbreaking biomedical technologies.”
The discussions also centered on the immediate needs of institutions like Stony Brook University, where innovative research is pushing the boundaries of what is possible in medicine. Researchers like Mujica-Parodi and Balázsi contribute to advancements that could lead to new treatments for neurological disorders, cancer and other life-threatening conditions. However, these breakthroughs require sustained federal support.
AIMBE’s Capitol Hill Day serves as a critical platform for advocacy, enabling researchers to directly engage with national policymakers and advocate for legislation that supports biomedical advancements. The meetings between SBU researchers and congressional staff underscored the importance of this ongoing dialogue and the necessity of federal investment to fuel the next generation of medical breakthroughs.
Stony Brook’s Office of Federal Relations joined Mujica-Parodi and Balázsi during the AIMBE Hill visits and works on a daily basis with the New York congressional delegation to advance SBU’s federal priorities.
Add comment